BOBULSKY SUSAN
Chief Commercial Officer, MRD
5 filings on record here, covering ADPT. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-12
| Sell | ADPT | Adaptive Biotechnologies Corp | $75,000 |
CORPORATEFiled 2026-08-03
| Sell | ADPT | Adaptive Biotechnologies Corp | $31,176 |
CORPORATEFiled 2026-07-06
| Sell | ADPT | Adaptive Biotechnologies Corp | $10,714 |
CORPORATEFiled 2026-06-29
| Sell | ADPT | Adaptive Biotechnologies Corp | $102,500 |
CORPORATEFiled 2026-06-15
| Sell | ADPT | Adaptive Biotechnologies Corp | $95,000 |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.